Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biodesix Inc (NQ: BDSX )

1.480 -0.130 (-8.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 178,867
Open 1.660
Bid (Size) 1.430 (1)
Ask (Size) 1.550 (24)
Prev. Close 1.610
Today's Range 1.414 - 1.660
52wk Range 1.310 - 16.39
Shares Outstanding 39,790,784
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Biodesix to Present at the H.C. Wainwright Global Investment Conference
From Biodesix, Inc.
Via Business Wire
Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to be Presented at ATS 2022 International Conference
From Biodesix, Inc.
Via Business Wire

Performance

YTD
-74.53%
-74.53%
1 Month
-4.52%
-4.52%
3 Month
-53.31%
-53.31%
6 Month
-76.80%
-76.80%
1 Year
-89.03%
-89.03%

More News

Read More
Recap: Biodesix Q1 Earnings
Via Benzinga
Biodesix Announces First Quarter 2022 Results and Highlights
From Biodesix, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Recap: Biodesix Q4 Earnings
Via Benzinga
Preview: Biodesix's Earnings
Via Benzinga
66 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Biodesix to Report First Quarter 2022 Financial Results on May 11, 2022
From Biodesix, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2022
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
68 Biggest Movers From Yesterday
Via Benzinga
The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More
Via Benzinga
A Peek Into The Markets: US Stock Futures Down Ahead Of March Inflation Report
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Why This Nano-Cap Healthcare Stock Spiked Over 80% After-Hours Today
Via Benzinga
Biodesix Strengthens Financial Position with Equity Issuance and Amendment to Term Loan
From Biodesix, Inc.
Via Business Wire
Biodesix Announces Publication Further Validating the Use of Liquid Biopsies and NGS Techniques to Provide Clinical Information for Patients With Cancer
From Biodesix, Inc.
Via Business Wire
Biodesix's Return On Capital Employed Insights
Via Benzinga
Biodesix Announces Fourth Quarter and Year End 2021 Results and Highlights
From Biodesix
Via Business Wire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Earnings Scheduled For March 14, 2022
Via Benzinga
The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.